Jaw osteonecrosis induced by oral biphosphonates: 12 cases;Ostéonécroses des mâchoires induites par les biphosphonates oraux: 12 cas

Revue de Stomatologie et de Chirurgie Maxillo-Faciale

Volumn 111, Issue 4, 2010, Pages 196-202

  Barrier, A ^a   Lescaille, G ^b   Rigolet, A ^a,c   Descroix, V ^b,c   Goudot, P ^b,c   Ruhin, B ^b,c  

^a SAINT LOUIS HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Biphosphonates; Jaw; Oral administration; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CORTICOSTEROID; DRUG DERIVATIVE; ETIDRONIC ACID; RISEDRONIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BONE NECROSIS; BONE TUMOR; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; DELAYED DIAGNOSIS; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; JAW DISEASE; MALE; METASTASIS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; TIME; TOOTH EXTRACTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ALENDRONATE; AUTOIMMUNE DISEASES; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; CHRONIC DISEASE; DELAYED DIAGNOSIS; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAW DISEASES; MALE; MANDIBULAR DISEASES; MIDDLE AGED; OSTEONECROSIS; OSTEOPOROSIS; TIME FACTORS; TOOTH EXTRACTION; TREATMENT OUTCOME;

EID: 77956610412     PISSN: 00351768     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stomax.2010.07.009     Document Type: Article

References (11)

1. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
2. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of biphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
3. Y. Sawatari, and R.E. Marx Biphosphonates and biphosphonate induced osteonecrosis Oral Maxillofac Surg Clin North Am 19 2007 487 498
4. P.P. Sedghizadeh, K. Stanley, M. Caligiuri, S. Hofkes, B. Lowry, and C.F. Shuler Oral biphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry J Am Dent Assoc 140 2009 61 66
5. J.C. Lo, F.S. O'Ryan, N.P. Gordon, J. Yang, R.L. Hui, and D. Martin Prevalence of osteonecrosis of the jaw in patients with oral biphosphonate exposure J Oral Maxillofac Surg 68 2009 243 253
6. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, and B. Mehrotra American Association of Oral and Maxillofacial Surgeons position paper on biphosphonate-related osteonecrosis of the jaws - 2009 update J Oral Maxillofac Surg 67 2009 2 12
7. L.A. Assael Oral biphosphonates as a cause of biphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies J Oral Maxillofac Surg 67 2009 35 43
8. T. Mavrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of biphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423
9. I. Schirmer, H. Peters, P.A. Reichart, and H. Durkop Biphosphonates and osteonecrosis of the jaw Mund Kiefer Gesichtschir 9 2005 239 245
10. R.E. Marx, J.E. Cillo Jr., and J.J. Ulloa Oral biphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment J Oral Maxillofac Surg 65 2007 2397 2410
11. F.S. O'Ryan, S. Khoury, W. Liao, M.M. Han, R.L. Hui, and D. Baer Intravenous biphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator J Oral Maxillofac Surg 67 2009 1363 1372